{"disease":{"id":"brain-and-central-nervous-system-tumors","name":"brain and central nervous system tumors"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT00482677","title":"Radiation Therapy With or Without Temozolomide in Treating Older Patients With Newly Diagnosed Glioblastoma Multiforme","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":562,"lead_sponsor_name":"Canadian Cancer Trials Group","has_results":true},{"nct_id":"NCT00978458","title":"Radiation Therapy With or Without Temozolomide in Treating Patients With Low-Grade Glioma","phase":"PHASE3","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":540,"lead_sponsor_name":"Eastern Cooperative Oncology Group","has_results":false},{"nct_id":"NCT00089245","title":"Radiolabeled MAB Therapy in Patients With Refractory, Recurrent, or Advanced CNS or Leptomeningeal Cancer","phase":"PHASE1","overall_status":"TERMINATED","enrollment_count":177,"lead_sponsor_name":"Y-mAbs Therapeutics","has_results":false},{"nct_id":"NCT00897286","title":"Study of Stored Tumor Samples in Young Patients With Brain Tumors","phase":"","overall_status":"TERMINATED","enrollment_count":139,"lead_sponsor_name":"St. Jude Children's Research Hospital","has_results":false},{"nct_id":"NCT00005859","title":"Tipifarnib in Treating Patients With Recurrent or Progressive Malignant Glioma","phase":"PHASE1, PHASE2","overall_status":"COMPLETED","enrollment_count":136,"lead_sponsor_name":"Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins","has_results":false},{"nct_id":"NCT03150862","title":"A Study Assessing Pamiparib With Radiation and/or Temozolomide (TMZ) in Participants With Newly Diagnosed or Recurrent Glioblastoma","phase":"PHASE1, PHASE2","overall_status":"COMPLETED","enrollment_count":116,"lead_sponsor_name":"BeiGene USA, Inc.","has_results":true},{"nct_id":"NCT00720356","title":"Bevacizumab and Erlotinib After Radiation Therapy and Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma Multiforme or Gliosarcoma","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":115,"lead_sponsor_name":"Northwestern University","has_results":true},{"nct_id":"NCT00010049","title":"Imatinib Mesylate in Treating Patients With Recurrent Malignant Glioma or Meningioma","phase":"PHASE1, PHASE2","overall_status":"COMPLETED","enrollment_count":105,"lead_sponsor_name":"Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins","has_results":false},{"nct_id":"NCT00025675","title":"Gefitinib in Treating Patients With Recurrent or Progressive CNS Tumors","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":105,"lead_sponsor_name":"Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins","has_results":false},{"nct_id":"NCT00293423","title":"GP96 Heat Shock Protein-Peptide Complex Vaccine in Treating Patients With Recurrent or Progressive Glioma","phase":"PHASE1, PHASE2","overall_status":"COMPLETED","enrollment_count":96,"lead_sponsor_name":"University of California, San Francisco","has_results":true},{"nct_id":"NCT00003176","title":"Temozolomide and Carmustine in Treating Patients With Anaplastic Glioma","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":82,"lead_sponsor_name":"Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins","has_results":false},{"nct_id":"NCT00752323","title":"Imaging Procedure Using ALA in Finding Residual Tumor in Grade IV Malignant Astrocytoma","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":73,"lead_sponsor_name":"Andrew Sloan, MD","has_results":false},{"nct_id":"NCT00905060","title":"HSPPC-96 Vaccine With Temozolomide in Patients With Newly Diagnosed GBM","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":70,"lead_sponsor_name":"University of California, San Francisco","has_results":true},{"nct_id":"NCT00070161","title":"Phase II Studies Of Donepezil And Ginkgo Biloba In Irradiated Brain Tumor","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":68,"lead_sponsor_name":"Wake Forest University Health Sciences","has_results":false},{"nct_id":"NCT00058123","title":"Poly-ICLC in Treating Patients With Recurrent or Progressive Anaplastic Glioma","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":55,"lead_sponsor_name":"Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins","has_results":true},{"nct_id":"NCT00022724","title":"CCI-779 in Treating Patients With Malignant Glioma","phase":"PHASE1, PHASE2","overall_status":"COMPLETED","enrollment_count":49,"lead_sponsor_name":"Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins","has_results":false},{"nct_id":"NCT00006358","title":"Temozolomide Plus Thalidomide in Treating Patients With Recurrent or Progressive Brain Tumor","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":44,"lead_sponsor_name":"Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins","has_results":false},{"nct_id":"NCT07416188","title":"Novel Indenoisoquinolone CMYC/TOPOISOMERASE 1 Inhibitor (LMP744) in Recurrent Glioblastoma","phase":"PHASE1, PHASE2","overall_status":"NOT_YET_RECRUITING","enrollment_count":40,"lead_sponsor_name":"National Institute of Neurological Disorders and Stroke (NINDS)","has_results":false},{"nct_id":"NCT00974987","title":"Boron Neutron Capture Therapy, Radiation Therapy, and Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma Multiforme","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":32,"lead_sponsor_name":"Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan","has_results":false},{"nct_id":"NCT00387400","title":"Temozolomide + Everolimus in Newly Diagnosed, Recurrent, or Progressive Malignant Glioblastoma Multiforme","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":32,"lead_sponsor_name":"NCIC Clinical Trials Group","has_results":false},{"nct_id":"NCT00052715","title":"Biological Therapy and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme","phase":"PHASE2","overall_status":"TERMINATED","enrollment_count":31,"lead_sponsor_name":"Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins","has_results":true},{"nct_id":"NCT03696355","title":"Study of GDC-0084 in Pediatric Patients With Newly Diagnosed Diffuse Intrinsic Pontine Glioma or Diffuse Midline Gliomas","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":27,"lead_sponsor_name":"St. Jude Children's Research Hospital","has_results":false},{"nct_id":"NCT00998010","title":"Bortezomib, Temozolomide, and Regional Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme or Gliosarcoma","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":24,"lead_sponsor_name":"Jonsson Comprehensive Cancer Center","has_results":true},{"nct_id":"NCT00770471","title":"ABT-888, Radiation Therapy, and Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma Multiforme","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":24,"lead_sponsor_name":"Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins","has_results":false},{"nct_id":"NCT00007813","title":"Peripheral Stem Cell Transplantation Plus Chemotherapy in Treating Patients With Malignant Solid Tumors","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":21,"lead_sponsor_name":"Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins","has_results":false},{"nct_id":"NCT00079092","title":"Thalidomide and Procarbazine in Treating Patients With Recurrent or Progressive Malignant Glioma","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":18,"lead_sponsor_name":"Wake Forest University Health Sciences","has_results":false},{"nct_id":"NCT00003372","title":"Topotecan in Treating Patients With Recurrent Brain Tumors","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":17,"lead_sponsor_name":"NCIC Clinical Trials Group","has_results":false},{"nct_id":"NCT00238277","title":"Temozolomide During and After Radiation Therapy in Treating Patients Who Have Undergone Previous Surgery and Placement of Gliadel Wafers for Newly Diagnosed Glioblastoma Multiforme","phase":"PHASE2","overall_status":"TERMINATED","enrollment_count":15,"lead_sponsor_name":"Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins","has_results":false},{"nct_id":"NCT00436436","title":"O(6)-Benzylguanine and Temozolomide in Treating Patients With Glioblastoma Multiforme That Did Not Respond to Previous Temozolomide and Radiation Therapy","phase":"PHASE2","overall_status":"TERMINATED","enrollment_count":12,"lead_sponsor_name":"National Cancer Institute (NCI)","has_results":true},{"nct_id":"NCT06742593","title":"Study of MT027 in Patients with Brain, Meninges, and Spinal Cord Metastatic Solid Tumors","phase":"PHASE1","overall_status":"NOT_YET_RECRUITING","enrollment_count":12,"lead_sponsor_name":"Suzhou Maximum Bio-tech Co., Ltd.","has_results":false},{"nct_id":"NCT00471653","title":"Pharmacokinetics in Patients With Newly Diagnosed High-Grade Glioma Receiving Temozolomide and Radiation Therapy","phase":"","overall_status":"TERMINATED","enrollment_count":10,"lead_sponsor_name":"Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins","has_results":false},{"nct_id":"NCT00036660","title":"SarCNU in Treating Patients With Recurrent Malignant Glioma","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":10,"lead_sponsor_name":"NCIC Clinical Trials Group","has_results":false},{"nct_id":"NCT03965494","title":"AXL Inhibitor BGB324 in Treating Participants With Recurrent Glioblastoma Undergoing Surgery","phase":"EARLY_PHASE1","overall_status":"TERMINATED","enrollment_count":10,"lead_sponsor_name":"Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins","has_results":false},{"nct_id":"NCT00788125","title":"Dasatinib, Ifosfamide, Carboplatin, and Etoposide in Treating Young Patients With Metastatic or Recurrent Malignant Solid Tumors","phase":"PHASE1, PHASE2","overall_status":"TERMINATED","enrollment_count":7,"lead_sponsor_name":"City of Hope Medical Center","has_results":true},{"nct_id":"NCT00006452","title":"Gadolinium Texaphyrin Plus Radiation Therapy in Treating Patients With Supratentorial Glioblastoma Multiforme","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":6,"lead_sponsor_name":"Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins","has_results":false},{"nct_id":"NCT00401024","title":"Tumor Tissue Analysis in Patients Receiving Imatinib Mesylate for Malignant Glioma","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":3,"lead_sponsor_name":"Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins","has_results":false},{"nct_id":"NCT00621036","title":"Vaccine Therapy and GM-CSF in Treating Patients With CNS Lymphoma","phase":"PHASE2","overall_status":"WITHDRAWN","enrollment_count":0,"lead_sponsor_name":"University of Texas Southwestern Medical Center","has_results":false},{"nct_id":"NCT00433472","title":"MRI in Evaluating the Effect of Efaproxiral on the Brain in Patients With Recurrent or Progressive Glioma Enrolled on Clinical Trial NABTT-9806","phase":"NA","overall_status":"WITHDRAWN","enrollment_count":0,"lead_sponsor_name":"Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins","has_results":false},{"nct_id":"NCT00004041","title":"Gene Therapy in Treating Patients With Recurrent Malignant Gliomas","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":null,"lead_sponsor_name":"Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins","has_results":false},{"nct_id":"NCT00003616","title":"Irinotecan in Treating Patients With Progressive or Recurrent Malignant Glioma","phase":"PHASE1, PHASE2","overall_status":"COMPLETED","enrollment_count":null,"lead_sponsor_name":"Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins","has_results":false},{"nct_id":"NCT00006080","title":"Fenretinide in Treating Patients With Recurrent Malignant Glioma","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":null,"lead_sponsor_name":"Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins","has_results":false},{"nct_id":"NCT00049361","title":"Radiation Therapy Plus Thalidomide and Temozolomide in Treating Patients With Newly Diagnosed Brain Metastases","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":null,"lead_sponsor_name":"Wake Forest University Health Sciences","has_results":false},{"nct_id":"NCT00004868","title":"SU5416 in Treating Patients With Recurrent Astrocytoma or Mixed Glioma That Has Not Responded to Radiation Therapy","phase":"PHASE1, PHASE2","overall_status":"COMPLETED","enrollment_count":null,"lead_sponsor_name":"Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins","has_results":false},{"nct_id":"NCT00031798","title":"Methylphenidate to Improve Quality of Life in Patients Undergoing Radiation Therapy for Brain Tumors","phase":"PHASE3","overall_status":"TERMINATED","enrollment_count":null,"lead_sponsor_name":"Wake Forest University Health Sciences","has_results":false},{"nct_id":"NCT00002971","title":"O(6)-Benzylguanine in Treating Patients With Malignant Glioma","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":null,"lead_sponsor_name":"Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins","has_results":false},{"nct_id":"NCT00027625","title":"Gefitinib Plus Temozolomide in Treating Patients With Malignant Primary Glioma","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":null,"lead_sponsor_name":"Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins","has_results":false},{"nct_id":"NCT00006025","title":"Temozolomide Plus Irinotecan in Treating Patients With Recurrent Malignant Glioma","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":null,"lead_sponsor_name":"Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins","has_results":false}],"total":47},"guidelines":[],"source":"Drug Landscape verified database"}